Montelukast Prescribing at DR SHARMA & PARTNERS
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
172
Total Quantity
5,411
NHS Cost
£262
vs National Avg
-74.9%
DR SHARMA & PARTNERS prescribed 172 items of Montelukast over the last 12 months at a cost of £262 to the NHS. This is 74.9% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
18
Jul 2026
14
Jul 2026
17
Jul 2026
15
Jul 2026
13
Jul 2026
17
Jul 2026
13
Jul 2026
13
Jul 2026
16
Jul 2026
10
Jul 2026
13
Jul 2026
13
Prescribing Details
| Total Items | 172 |
|---|---|
| Total Quantity | 5,411 |
| Total NHS Cost | £262 |
| Presentations | 3 different forms |
| vs National Average | -74.9% |
Montelukast Prescribing Comparison
| This practice | 172 items |
|---|---|
| National average per practice | 685 items |
| Difference | -74.9% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.